Savara to present at the h.c. wainwright 25th annual global investment conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the h.c. wainwright 25th annual global investment conference on september 12, 2023 at 3:30pm et/12:30pm pt. a live webcast of the presentation will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara savara is a clin.
SVRA Ratings Summary
SVRA Quant Ranking